CATEGORIES

Pharmaceutics

LATEST

TRENDING

EDITORS CHOICE

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Colchicine Shows 48% Reduction in Future Cardio Issues for Heart Attack Victims

Early, in-hospital treatment with colchicine reduces the odds of future cardiovascular problems by 48% in people who have just survived a heart attack

Ivermectin is NOT Hydroxychloroquine. Why is the FDA Ignoring a Potential Covid Treatment?

Ivermectin has shown promise as a potential treatment. It needs to be urgently evaluated under the guidance of the FDA

Lilly commits Insulin Value Program, With $35 Copay Card

Anyone with commercial insurance, and those without insurance at all, can continue filling their monthly prescription of Lilly insulins for $35 through this program.